The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company has C$8.15 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2024-12-31 | $C$8.43 B | 2.03% |
2023-12-31 | $C$8.26 B | 66.39% |
2022-12-31 | $C$4.96 B | -41.82% |
2021-12-31 | $C$8.53 B | -28.83% |
2020-12-31 | $C$11.99 B | -5.04% |
2019-12-31 | $C$12.63 B | -25.81% |
2018-12-31 | $C$17.02 B | -46.34% |
2017-12-31 | $C$31.73 B | -20.96% |
2016-12-31 | $C$40.14 B | 3.06% |
2015-12-31 | $C$38.95 B | 30.23% |
2014-12-31 | $C$29.91 B | 27.18% |
2013-12-31 | $C$23.52 B | 24.1% |
2012-12-31 | $C$18.95 B | -2.08% |
2011-12-31 | $C$19.35 B | -19.13% |
2010-12-31 | $C$23.93 B | 0.35% |
2009-12-31 | $C$23.85 B | -3.78% |
2008-12-31 | $C$24.78 B | 39.05% |
2007-12-31 | $C$17.82 B | -19.27% |
2006-12-31 | $C$22.07 B | -7.27% |
2005-12-31 | $C$23.81 B | 0.6% |
2004-12-31 | $C$23.66 B | -5.9% |
2003-12-31 | $C$25.15 B | -12.91% |
2002-12-31 | $C$28.88 B | 247.49% |
2001-12-31 | $C$8.31 B |